[HTML][HTML] Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
…, I Silva, B Milbes, N Kojima, V Hess, M Shacreaw… - Nature, 2022 - nature.com
SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals
infected with Delta are at risk of developing severe lung disease, infection with Omicron …
infected with Delta are at risk of developing severe lung disease, infection with Omicron …
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
…, N Kojima, V Hess, M Shacreaw… - Proceedings of the …, 2022 - National Acad Sciences
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant contains
extensive sequence changes relative to the earlier-arising B.1, B.1.1, and Delta SARS-…
extensive sequence changes relative to the earlier-arising B.1, B.1.1, and Delta SARS-…
[HTML][HTML] Unique immune and inflammatory cytokine profiles may define long COVID syndrome
…, N Denny, MA MacMullan, V Hess, M Shacreaw… - Clinical and …, 2023 - Springer
Purpose Long COVID is estimated to occur in 5–10% of individuals after acute SARS-CoV-2
infection. However, the pathophysiology driving the disease process is poorly understood. …
infection. However, the pathophysiology driving the disease process is poorly understood. …
Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
…, A Bussanich, V Hess, M Shacreaw… - Emerging Microbes & …, 2023 - Taylor & Francis
The emergence of SARS-CoV-2 recombinants is of particular concern as they can result in
a sudden increase in immune evasion due to antigenic shift. Recent recombinants XBB and …
a sudden increase in immune evasion due to antigenic shift. Recent recombinants XBB and …
[HTML][HTML] Local monitoring of SARS-CoV-2 variants in two large California counties in 2021
…, S Quasem, N Sandhu, E Salfati, M Shacreaw… - Scientific Reports, 2022 - nature.com
Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), continues to persist due to mutations resulting in newer, more …
coronavirus 2 (SARS-CoV-2), continues to persist due to mutations resulting in newer, more …
A booster dose of either BNT162b2 or mRNA-1273 mRNA vaccines induces a robust recall of anti-SARS-CoV-2 spike protein IgG antibodies in saliva
…, AN Angel, MA MacMullan, M Shacreaw… - Authorea …, 2023 - essopenarchive.org
Saliva specimens offer practical advantages over serum specimens for studying SARS-CoV-2
immunity following natural infections or vaccination. Salivary anti-spike (S)-protein …
immunity following natural infections or vaccination. Salivary anti-spike (S)-protein …
Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination (preprint)
…, I Silva, B Milbes, N Kojima, V Hess, M Shacreaw… - 2022 - pesquisa.bvsalud.org
SARS-CoV-2 Delta and Omicron strains are the most globally relevant variants of concern (VOCs).
While individuals infected with Delta are at risk to develop severe lung disease 1, …
While individuals infected with Delta are at risk to develop severe lung disease 1, …
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles (preprint)
…, I Silva, B Milbes, N Kojima, V Hess, M Shacreaw… - 2021 - pesquisa.bvsalud.org
The Omicron SARS-CoV-2 virus contains extensive sequence changes relative to the earlier
arising B. 1, B. 1.1 and Delta SARS-CoV-2 variants that have unknown effects on viral …
arising B. 1, B. 1.1 and Delta SARS-CoV-2 variants that have unknown effects on viral …
[HTML][HTML] Participant characteristics
N Kojima, JD Klausner - mlo-online.com
We enrolled adults (18 years or older) in Los Angeles County and Riverside County who
recently tested positive for SARS-CoV-2 by PCR (Curative, San Dimas, CA). Participants were …
recently tested positive for SARS-CoV-2 by PCR (Curative, San Dimas, CA). Participants were …
[PDF][PDF] … in vivo Taha Y. Taha, Rahul K. Suryawanshi, Irene P. Chen, Galen J. Correy, Patrick C. O'Leary2, Manasi P. Jogalekar2, Maria McCavitt-Malvido1, Morgan E …
NJ Martinez-Sobrido, A Ashworth, JS Fraser, M Ott… - scienceopen.com
Despite unprecedented efforts, our therapeutic arsenal against SARS-CoV-2 remains limited.
The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP-…
The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP-…